Understanding C. difficile infection and treatment effects
Treatments studied
Part of Infections clinical trials.
This study is tracking patients with a confirmed C. difficile infection to understand how the body responds and how treatments work. You may be asked to do follow-up visits for up to 5 years.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 years or older
- You must have a confirmed C. difficile infection with symptoms
- You are being treated at Umeå University Hospital (inpatient or outpatient)
- You must be willing and able to provide written consent and complete follow-ups for up to 5 years
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study follows patients who were treated for a C. difficile infection (a serious gut bacteria infection) at Umeå University Hospital to compare how well they recover long-term with either a fecal microbiota transplant (FMT—transferring healthy gut bacteria from a donor) or antibiotic treatment alone.
This trial tests whether giving a stool transplant (also called FMT) can treat a new, early C. difficile infection in people who have improved while on antibiotics. It may help some people prevent the infection from coming back or worsening.
This trial tests a new treatment called CMTS0929 for people with C. diff infection. It aims to see if the treatment can help clear the infection and improve symptoms.
This study tests whether taking a capsule form of fecal microbiota transplant (FMT) can help adults with their first C. difficile infection—or a first relapse—get better and reduce repeat episodes. Participants also take specific antibiotics for C. difficile as part of the study process.
This study tests whether specific lifestyle changes during treatment for C. difficile infection (a serious gut bacteria infection) can help prevent it from coming back. You'll receive standard antibiotic treatment and follow a controlled diet while researchers track your recovery.
This study follows patients with Clostridioides difficile (C. diff) infection to see how their symptoms improve and when the bacteria clear from their body. It aims to better understand recovery and guide treatment.
Hear when a new Clostridioides Difficile Infection trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.